Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > FDA EUA

<< Previous

Bullboard Posts

Next >>

Comment by ragb7002on Jan 01, 2021 10:03am

71 Views

Post# 32207064

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA EUA

Thoughts. They projected 20 will have12. They don't seem to be very active in any sales to markets that don't need fda approval. Why? I don't know. At the rate of cash burn there is a possibility of dilution if they don't get off their butts. $600k/month25 =24 mth and that's Gross. FDA approval IMO won't be anytime soon. Spoon it's all speculation at this time.

<< Previous

Bullboard Posts

Next >>

Three business reasons companies need to recycle e-waste